Endeavor BioMedicines

Pushing Boundaries to Change Lives

San Diego, United States · Founded 2019 · $295.5M raised

Headquarters
San Diego
Founded
2019
Business Model
B2B
Total Funding
$295.5M
Last Round
$132.5M Series CApr 2024
Rounds
3

About

Endeavor BioMedicines is a clinical-stage biotechnology company headquartered in San Diego that develops transformational medicines for patients with life-threatening and intractable diseases. Co-founded by CEO John Hood, PhD, the company's lead pipeline targets fibrotic lung disease, including Taladegib (ENV-101), which aims to reverse rather than merely slow disease progression and has received PRIME designation from the European Medicines Agency. Endeavor has raised financing including a $132.5 million oversubscribed Series C round to advance its pipeline.

Summary

Endeavor BioMedicines is a Biotech company based in San Diego, United States, founded in 2019. It has raised $295.5M in total across 3 rounds, most recently a $132.5M Series C round in Apr 2024. Investors include Matrix Capital Management, Ally Bridge Group and Fidelity Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CApr 2024
$132.5M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Endeavor BioMedicines on Indexed.vc
<a href="https://indexed.vc/companies/endeavor-biomedicines"><img src="https://indexed.vc/api/badge/company/endeavor-biomedicines" alt="Endeavor BioMedicines on Indexed.vc" width="260" height="76" /></a>